Serum uric acid levels as a causal factor in hypertension: Insights from Mendelian randomization analysis

Jiayue Xu1, Jiajing Zhao2, Jiaming Gu3

  • 1Department of Traditional Chinese Medicine, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, Shanghai, China.

Insights

High serum uric acid (SUA) levels causally increase hypertension risk. This Mendelian randomization study confirms a one-way link, highlighting SUA management for blood pressure control.

Area of Science:

  • Genetics
  • Epidemiology
  • Cardiovascular Disease

Background:

  • Hyperuricemia and hypertension are common, often co-occurring chronic diseases.
  • Observational studies suggest a link between serum uric acid (SUA) and hypertension, but causality is unclear due to confounding factors.
  • This study uses Mendelian randomization (MR) to investigate the causal relationship between SUA levels and hypertension risk.

Purpose of the Study:

  • To determine if elevated serum uric acid (SUA) levels causally influence the risk of developing hypertension.
  • To differentiate the direction of causality between SUA and blood pressure using genetic variants.
  • To provide robust evidence mitigating confounding and reverse causation inherent in observational studies.

Main Methods:

  • Employed Mendelian randomization (MR) using single nucleotide polymorphisms (SNPs) as genetic instruments for serum uric acid (SUA) levels.
  • Utilized a two-sample MR design with GWAS data from European populations.
  • Assessed systolic and diastolic blood pressure as outcomes, with sensitivity analyses including weighted median and MR-Egger.

Main Results:

  • Genetically predicted higher SUA levels showed a significant positive causal association with increased systolic blood pressure (SBP) and diastolic blood pressure (DBP).
  • Reverse MR analysis indicated no significant causal effect of SBP or DBP on SUA levels, confirming a unidirectional relationship.
  • Findings suggest a causal link where elevated SUA contributes to hypertension development.

Conclusions:

  • This MR study provides strong evidence for a unidirectional causal relationship between higher SUA levels and an increased risk of hypertension.
  • The findings underscore the clinical significance of managing SUA levels to reduce hypertension risk.
  • Further research, including RCTs, is warranted to confirm these results and explore SUA-targeted interventions.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
569
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
439
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
376
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
2.7K